NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States Subjects Government Regulation Remove constraint Subjects: Government Regulation Languages English Remove constraint Languages: English

Search Results

1. Data inadequacies undermine CMS's oversight of the inconsistency resolution process for the federal marketplace

2. CDC generally met its inspection goals for the federal select agent program: however, opportunities exist to strengthen oversight

4. Medicaid Fraud Control Units: investigation and prosecution of fraud and beneficiary abuse in Medicaid personal care services

5. Deciphering the data: health insurance marketplace enrollment rates by type of exchange

6. Deciphering the data: health insurance rates and rate review

7. Creating seamless coverage transitions between Medicaid and the exchanges

9. Physician-hospital integration 2012: how health care reform is reshaping California's delivery system

12. Olive-drab service uniform: supplement no. 1 to regulations governing the uniforms of officers and employees of the United States Public Health Service

14. Food Safety: a national strategy is needed to address fragmentation in federal oversight : report to Congressional requesters

15. Medicaid managed care: improved oversight needed of payment rates for long-term services and supports : report to Congressional requesters

16. Foster care: HHS has taken steps to support states' oversight of psychotropic medications, but additional assistance could further collaboration : report to Congressional requesters

18. Medicaid demonstrations: federal action needed to improve oversight of spending : report to the Chairman, Committee on Finance, U.S. Senate

19. Medicare advantage: CMS should use data on disenrollment and beneficiary health status to strengthen oversight : report to Congressional Requesters

20. Medicaid personal care services: more harmonized program requirements and better data are needed : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

21. The Commonwealth Fund / National Opinion Research Center Survey of Retiree Health Benefits, 2005: a chartbook

22. Equity measures and systems reform as tools for reducing racial and ethnic disparities in health care

23. Key issues in long-term services and supports quality

25. Health care opinion leaders' views on health reform and the role of states

28. Program integrity after the enactment of health reform

29. Errors in radiation therapy

30. State regulation of coverage options outside of the Affordable Care Act: limiting the risk to the individual market

32. The clinic's tale: chasing FQHC status not for the faint-hearted

33. Memory supplements: clarifying FDA and FTC roles could strengthen oversight and enhance consumer awareness : report to Congressional requesters

34. Improper payments: improvements needed in CMS and IRS controls over health insurance premium tax credit : report to Congressional committees

35. Air ambulance: data collection and transparency needed to enhance DOT oversight : report to the Committee on Transportation and Infrastructure, House of Representatives

36. Drug discount program: update on agency efforts to improve 340B program oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

37. Health insurance marketplaces: CMS needs to improve its oversight of state IT systems' sustainability and performance : report to Congressional requesters

38. Medicaid managed care: CMS should improve oversight of access and quality in states' long-term services and supports programs : report to Congressional requesters

39. VA health care: opportunities exist for improving implementation and oversight of enrollment processes for veterans : report to Congressional committees

56. Letter of the Secretary of War: communicating, in answer to a resolution of the Senate of the 9th instant, copy of the proceedings of the general court-martial for the trial of assistant surgeon Webster : report of the general-in-chief of the Army on the management of general hospitals : general orders in relation to the medical department, and general orders and instructions relating to hospitals

58. Recognizing destabilization in the individual health insurance market

59. Short-term, limited-duration insurance and risks to California's insurance market

60. Ensuring health plan mergers benefit the community: California regulators and infrastructure investment programs

61. Imported seafood safety: FDA and USDA could strengthen efforts to prevent unsafe drug residues : report to the chairman, Committee on Appropriations, U.S. Senate

62. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters

63. High-containment laboratories: coordinated efforts needed to further strengthen oversight of select agents : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

64. VA health care: improved policies and oversight needed for reviewing and reporting providers for quality and safety concerns : report to the chairman, Committee on Veterans' Affairs, House of Representatives

65. VA health care: improved oversight needed for reviewing and reporting providers for quality and safety concerns : testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives

66. Medicaid: further action needed to expedite use of national data for program oversight : report to Congressional requesters

67. FDA medical device reviews: evaluation is needed to assure requests for additional information follow a least burdensome approach : report to Congressional requestors

68. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

69. Implantable devices: regulatory framework and reform options

70. Public funding and support of assistive technologies for persons with disabilities

71. Bridging the gaps: state and local strategies for ensuring backup personal care services

73. Can 1 + 1 = 3?: a look at hybrid insurance products with long-term care insurance

74. Exploring the role of cost-benefit analysis in government regulations

75. Safe at home?: Developing effective criminal background checks and other screening policies for home care workers

76. California's nurse practitioners: how scope of practice laws impact care

77. Immigration detention: ICE needs to strengthen oversight of informed consent for medical care : report to congressional requesters

78. Maternal health: Outcomes worsened and disparities persisted during the pandemic : report to congressional addressees

79. Maternal health: Availability of hospital-based obstetric care in rural areas : report to congressional committees

80. Medicare: CMS needs to address risks posed by provider enrollment waivers and flexibilities : report to congressional committees

81. Veterans health care: VA actions needed to ensure timely scheduling of specialty care appointments : report to congressional committees

82. Federal Employees Health Benefits Program: Additional monitoring mechanisms and fraud risk assessment needed to better ensure member eligibility : report to congressional requesters

83. Abuse and neglect: CMS should strengthen reporting requirements to better protect individuals receiving hospice care : report to the Honorable Charles E. Grassley, United States Senate

84. Public health preparedness: HHS could improve oversight of research involving enhanced potential pandemic pathogens : report to congressional committees

85. Medicare Advantage: Plans generally offered some supplemental benefits, but CMS has limited data on utilization : report to congressional committees

86. Nursing homes: CMS should make ownership information more transparent for consumers : report to the Honorable Richard Neal, House of Representatives

87. Institutional review boards: Actions needed to improve federal oversight and examine effectiveness : report to congressional requesters

88. Tracking the funds: specific fiscal year 2022 provisions for Department of Health and Human Services : report to congressional committees

89. Routine vaccinations: adult rates vary by vaccine type and other factors : report to congressional requesters

90. Public health preparedness: HHS should address strategic national stockpile requirements and inventory risks : report to congressional addressees

95. Pharmacokinetic-based criteria for supporting alternative dosing regimens of programmed cell death receptor-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) blocking antibodies for treatment of patients with cancer: guidance for industry

98. Referencing the definition of “device” in the Federal Food, Drug, and Cosmetic Act in guidance, regulatory documents, communications, and other public documents: guidance for industry and Food and Drug Administration staff